| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.912 | 0.001 | 0.912 | Acetylcholine nicotinic antagonist | 0.892 0.002 DBMET00673 | ||
| 0.854 | 0.002 | 0.854 | Cholinergic antagonist | 0.821 0.002 DBMET00673 | ||
| 0.851 | 0.002 | 0.851 | Acetylcholine antagonist | 0.82 0.002 DBMET00673 | ||
| 0.654 | 0.004 | 0.684 | Anesthetic general | 0.684 0.004 DBMET00673 | DBMET00673 | |
| 0.578 | 0.054 | 0.578 | Apoptosis agonist | 0.519 0.069 DBMET00673 | ||
| 0.437 | 0.009 | 0.448 | Sodium/bile acid cotransporter inhibitor | 0.448 0.008 DBMET00673 | DBMET00673 | |
| 0.379 | 0.01 | 0.379 | Lipocortins synthesis antagonist | 0.364 0.012 DBMET00673 | ||
| 0.382 | 0.026 | 0.382 | Vasodilator | 0.277 0.057 DBMET00673 | ||
| 0.327 | 0.007 | 0.327 | Acetylcholine muscarinic antagonist | 0.32 0.008 DBMET00673 | ||
| 0.403 | 0.109 | 0.403 | Caspase 9 stimulant | 0.31 0.183 DBMET00673 | ||
| 0.348 | 0.065 | 0.348 | Cholesterol antagonist | 0.28 0.104 DBMET00673 | ||
| 0.346 | 0.078 | 0.346 | Transcription factor NF kappa B inhibitor | 0.226 0.145 DBMET00673 | ||
| 0.267 | 0.005 | 0.774 | Hedgehog signaling inhibitor | 0.774 0.003 DBMET00673 | DBMET00673 | |
| 0.276 | 0.015 | 0.276 | Anesthetic local | 0.242 0.022 DBMET00673 | ||
| 0.301 | 0.04 | 0.301 | Nitric oxide antagonist | 0.262 0.048 DBMET00673 | ||
| 0.257 | 0.003 | 0.257 | Glycine receptor agonist | 0.201 0.004 DBMET00673 | ||
| 0.315 | 0.065 | 0.315 | Spasmolytic | 0.234 0.098 DBMET00673 | ||
| 0.32 | 0.103 | 0.32 | Immunosuppressant | 0.226 0.17 DBMET00673 | ||
| 0.244 | 0.045 | 0.244 | Hepatoprotectant | 0.216 0.056 DBMET00673 | ||
| 0.281 | 0.084 | 0.281 | Immunostimulant | 0.202 0.119 DBMET00673 | ||
| 0.204 | 0.013 | 0.204 | Antineoplastic alkaloid | 0.172 0.022 DBMET00673 | ||
| 0.202 | 0.031 | 0.202 | Arachidonic acid antagonist | 0.186 0.047 DBMET00673 | ||
| 0.274 | 0.105 | 0.274 | Apoptosis antagonist | 0.218 0.158 DBMET00673 | ||
| 0.171 | 0.009 | 0.171 | Anabolic | 0.152 0.017 DBMET00673 | ||
| 0.157 | 0.01 | 0.157 | Acetylcholine M2 receptor antagonist | 0.095 0.023 DBMET00673 | ||
| 0.15 | 0.007 | 0.15 | Androgen agonist | 0.132 0.009 DBMET00673 | ||
| 0.172 | 0.034 | 0.172 | Farnesoid X receptor antagonist | 0.17 0.034 DBMET00673 | ||
| 0.14 | 0.004 | 0.174 | RNA-directed RNA polymerase stimulant | 0.174 0.003 DBMET00673 | DBMET00673 | |
| 0.25 | 0.115 | 0.25 | Immunomodulator | 0.234 0.128 DBMET00673 | ||
| 0.181 | 0.05 | 0.209 | NOS3 expression enhancer | 0.209 0.037 DBMET00673 | DBMET00673 | |
| 0.219 | 0.096 | 0.219 | DNA synthesis inhibitor | 0.174 0.162 DBMET00673 | ||
| 0.155 | 0.035 | 0.155 | Microtubule formation inhibitor | 0.105 0.081 DBMET00673 | ||
| 0.189 | 0.072 | 0.189 | P-glycoprotein inhibitor | |||
| 0.179 | 0.062 | 0.186 | Phospholipase C inhibitor | 0.186 0.055 DBMET00673 | DBMET00673 | |
| 0.138 | 0.026 | 0.138 | Acetylcholine M3 receptor agonist | 0.138 0.025 DBMET00673 | ||
| 0.129 | 0.04 | 0.135 | Estrogen antagonist | 0.135 0.033 DBMET00673 | DBMET00673 | |
| 0.108 | 0.024 | 0.108 | Na+ K+ transporting ATPase inhibitor | 0.104 0.028 DBMET00673 | ||
| 0.083 | 0.012 | 0.083 | Lipocortins synthesis agonist | 0.081 0.013 DBMET00673 | ||
| 0.101 | 0.031 | 0.116 | Glycine receptor antagonist | 0.116 0.021 DBMET00673 | DBMET00673 | |
| 0.087 | 0.021 | 0.09 | Estrogen agonist | 0.09 0.02 DBMET00673 | DBMET00673 | |
| 0.142 | 0.076 | 0.142 | Adenylate cyclase stimulant | |||
| 0.219 | 0.158 | 0.219 | Interleukin 2 agonist | 0.218 0.16 DBMET00673 | ||
| 0.123 | 0.063 | 0.123 | Cholesterol synthesis inhibitor | |||
| 0.063 | 0.006 | 0.071 | Glucose-6-phosphate dehydrogenase inhibitor | 0.071 0.005 DBMET00673 | DBMET00673 | |
| 0.143 | 0.088 | 0.143 | Interferon gamma antagonist | |||
| 0.104 | 0.051 | 0.104 | Prolactin inhibitor | 0.097 0.058 DBMET00673 | ||
| 0.181 | 0.133 | 0.181 | DNA damaging | |||
| 0.14 | 0.093 | 0.214 | Sigma receptor agonist | 0.214 0.057 DBMET00673 | DBMET00673 | |
| 0.067 | 0.02 | 0.067 | Acetyl-CoA transferase 2 inhibitor | 0.052 0.05 DBMET00673 | ||
| 0.206 | 0.16 | 0.206 | Caspase 3 stimulant | |||
| 0.089 | 0.046 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.042 DBMET00673 | DBMET00673 | |
| 0.094 | 0.051 | 0.101 | Androgen antagonist | 0.101 0.046 DBMET00673 | DBMET00673 | |
| 0.157 | 0.118 | 0.157 | Angiogenesis stimulant | |||
| 0.096 | 0.059 | 0.096 | Bile acid receptor antagonist | 0.095 0.061 DBMET00673 | ||
| 0.055 | 0.022 | 0.055 | Microtubule stabilization | |||
| 0.037 | 0.005 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.022 DBMET00673 | ||
| 0.084 | 0.061 | 0.084 | Transcription factor NF kappa B stimulant | |||
| 0.085 | 0.063 | 0.085 | Opioid antagonist | 0.081 0.068 DBMET00673 | ||
| 0.079 | 0.058 | 0.079 | Antineoplastic antibiotic | |||
| 0.045 | 0.028 | 0.045 | Opioid kappa receptor agonist | |||
| 0.093 | 0.077 | 0.105 | Estrogen receptor beta antagonist | 0.105 0.056 DBMET00673 | DBMET00673 | |
| 0.058 | 0.046 | 0.058 | Potassium channel (Ca-activated) blocker | |||
| 0.123 | 0.116 | 0.123 | Growth hormone agonist | |||
| 0.03 | 0.026 | 0.045 | Estrogen receptor alpha agonist | 0.045 0.019 DBMET00673 | DBMET00673 | |
| 0.02 | 0.016 | 0.02 | Corticosteroid-like | 0.019 0.018 DBMET00673 | ||
| 0.054 | 0.066 | 0.058 | Heme oxygenase stimulant | 0.058 0.052 DBMET00673 | DBMET00673 | |
| 0.056 | 0.073 | 0.061 | Prolactin release inhibitor | 0.061 0.047 DBMET00673 | DBMET00673 | |
| 0.041 | 0.06 | 0.05 | Acetylcholine M2 receptor agonist | 0.05 0.043 DBMET00673 | DBMET00673 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |